12-21437749-C-A

Variant summary

Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong

The NM_024854.5(PYROXD1):​c.19C>A​(p.Pro7Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000205 in 1,460,470 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P7S) has been classified as Uncertain significance.

Frequency

Genomes: not found (cov: 33)
Exomes 𝑓: 0.0000021 ( 0 hom. )

Consequence

PYROXD1
NM_024854.5 missense

Scores

1
18

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: -0.340
Variant links:
Genes affected
PYROXD1 (HGNC:26162): (pyridine nucleotide-disulphide oxidoreductase domain 1) This gene encodes a nuclear-cytoplasmic pyridine nucleotide-disulphide reductase (PNDR). PNDRs are flavoproteins that catalyze the pyridine nucleotide-dependent reduction of thiol residues in other proteins. The encoded protein belongs to the class I pyridine nucleotide-disulphide oxidoreductase family but lacks the C-terminal dimerization domain found in other family members and instead has a C-terminal nitrile reductase domain. It localizes to the nucleus and to striated sarcomeric compartments. Naturally occurring mutations in this gene cause early-onset myopathy with internalized nuclei and myofibrillar disorganization. A pseudogene of this gene has been defined on chromosome 11. [provided by RefSeq, Apr 2017]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.058870614).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
PYROXD1NM_024854.5 linkuse as main transcriptc.19C>A p.Pro7Thr missense_variant 1/12 ENST00000240651.14
PYROXD1XM_047429554.1 linkuse as main transcriptc.19C>A p.Pro7Thr missense_variant 1/10
PYROXD1XM_006719153.4 linkuse as main transcriptc.19C>A p.Pro7Thr missense_variant 1/8
PYROXD1NM_001350913.2 linkuse as main transcriptc.-685C>A 5_prime_UTR_variant 1/11

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
PYROXD1ENST00000240651.14 linkuse as main transcriptc.19C>A p.Pro7Thr missense_variant 1/121 NM_024854.5 P1Q8WU10-1
PYROXD1ENST00000544970.5 linkuse as main transcriptc.19C>A p.Pro7Thr missense_variant, NMD_transcript_variant 1/111
PYROXD1ENST00000543476.5 linkuse as main transcriptc.19C>A p.Pro7Thr missense_variant, NMD_transcript_variant 1/95
PYROXD1ENST00000375266.8 linkuse as main transcriptc.19C>A p.Pro7Thr missense_variant, NMD_transcript_variant 1/135

Frequencies

GnomAD3 genomes
Cov.:
33
GnomAD4 exome
AF:
0.00000205
AC:
3
AN:
1460470
Hom.:
0
Cov.:
33
AF XY:
0.00000275
AC XY:
2
AN XY:
726376
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00000270
Gnomad4 OTH exome
AF:
0.00
GnomAD4 genome
Cov.:
33

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsAug 17, 2022The c.19C>A (p.P7T) alteration is located in exon 1 (coding exon 1) of the PYROXD1 gene. This alteration results from a C to A substitution at nucleotide position 19, causing the proline (P) at amino acid position 7 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.063
BayesDel_addAF
Benign
-0.19
T
BayesDel_noAF
Benign
-0.52
CADD
Benign
2.2
DANN
Benign
0.95
DEOGEN2
Benign
0.011
T
Eigen
Benign
-1.0
Eigen_PC
Benign
-1.1
FATHMM_MKL
Benign
0.091
N
LIST_S2
Benign
0.48
T
M_CAP
Benign
0.0046
T
MetaRNN
Benign
0.059
T
MetaSVM
Benign
-0.99
T
MutationAssessor
Benign
0.18
N
MutationTaster
Benign
1.0
N;N;N
PrimateAI
Uncertain
0.56
T
PROVEAN
Benign
0.38
N
REVEL
Benign
0.024
Sift
Benign
0.067
T
Sift4G
Benign
0.26
T
Polyphen
0.0010
B
Vest4
0.19
MutPred
0.34
Gain of catalytic residue at K12 (P = 0.0044);
MVP
0.030
MPC
0.16
ClinPred
0.044
T
GERP RS
-1.2
Varity_R
0.034
gMVP
0.47

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

No publications associated with this variant yet.

Other links and lift over

hg19: chr12-21590683; API